Eli Lilly’s quarter wasn’t the cleanest but key drug updates speak to its robust pipeline – CNBC

  1. Eli Lilly’s quarter wasn’t the cleanest but key drug updates speak to its robust pipelineCNBC
  2. Eli Lilly cuts full year forecastWTHR
  3. Eli Lilly Is A Hold On Valuation Following Q2 ReportSeeking Alpha
  4. Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipelineCNBC Television
  5. Lilly Disappoints All Around But Here’s When I Would InvestRealMoney
  6. View Full Coverage on Google News

.

Leave a Comment

Your email address will not be published.